CLINICAL_TRIALS
trial_result
· 2019-10-09
Clinical Trial Update: TOLERA: Tolerance Enhancement in RA [Phase 2]
Summary
Phase 2 clinical trial update for TOLERA aiming at tolerance enhancement in rheumatoid arthritis; status not specified.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Erlangen-Nürnberg Medical School | Conditions: Rheumatoid Arthritis | Phase 2 | Status: UNKNOWN